Rob Griffiths

MeOmics capitalizes on recent advances in genetics and stem cell technology, combining genomics, phenomics and cellomics to create a unique Precision Psychiatry platform. The MeOmics platform, combining unique neuronal cell assays, data-rich descriptors of each individual and background genetics, brings the complexity of population level clinical trails to preclinical screening, prior to clinical trial expense. The MeOmics platform further brings the promise of personalized medicine to psychiatry, through the use of individual patient derived neurons for optimal treatment selection.